Over a relatively short time period a remarkable number of effective new therapies have been developed for patients with CLL. In some instances, these treatments have gained a marketing authorisation licence in Europe and, currently, some are funded within the NHS for patients who meet specific criteria. However, patients and clinicians should be mindful that this is a rapidly developing field that is likely to further evolve over the next year or two.
The CLL treatment landscape is beginning to change several new treatments have recently gained approval for treating CLL through the NHS following NICE & SMC recomendation and England Cancer Drugs Fund listing. Read update
June 2014- In this webcast video with slides Dr George Follows gives an overview of CLL and focuses on how CLL is treated. This picture is changing quite fast as new treatments have been approved over the past few months.
December 2014 - In this webcast video with slides Dr Claire Dearden provides an introductory overview of CLL followed with an update on CLL therapy following her return from the 2014 American Society of Haematology confereance.
Click on a link below to latest conversations in our on-line community discussing treatment and trials or on more about treatment and trials discussions